Filter
748
Text search:
Zhang,
J.
Featured
Recommendations
65
New Publications
86
Language
Document type
Studies & Reports
243
No document type
229
Guidelines
196
Manuals
32
Fact sheets
29
Strategic & Response Plan
8
Training Material
6
Situation Updates
2
Infographics
2
Brochures
1
Countries / Regions
Global
49
Russia
36
Brazil
21
Latin America and the Carribbean
14
Middle East and North Africa
13
India
12
Germany
12
Africa
12
South Africa
10
Syria
9
Yemen
9
Eastern Europe and Central Asia
9
China
8
Peru
8
Western and Central Europe
8
Mozambique
7
Ukraine
7
Asia
7
Eastern Europe
7
Spain
7
Philippines
6
Ecuador
6
Uganda
5
Angola
5
Myanmar / Burma
5
Chile
5
South–East Asia Region
5
Sierra Leone
4
South Sudan
4
Kenya
4
Tanzania
4
Indonesia
4
Sudan
4
Argentina
4
Colombia
4
West and Central Africa
4
Paraguay
4
Vietnam
4
Nigeria
3
Mali
3
Guinea-Bissau
3
Ethiopia
3
Cambodia
3
Bangladesh
3
Benin
3
Sri Lanka
3
North America
3
France
3
Burkina Faso
2
Senegal
2
Congo, Democratic Republic of
2
Ghana
2
Niger
2
Nepal
2
Botswana
2
Bolivia
2
Mexico
2
East and Southern Africa
2
Venezuela
2
Congo-Brazzaville
2
Canada
2
Tajikistan
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Zimbabwe
1
Haiti
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Chad
1
Thailand
1
Mauritania
1
Malawi
1
Dominican Republic
1
Namibia
1
Austria
1
Switzerland
1
Cuba
1
Honduras
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Lesotho
1
Nicaragua
1
Western Pacific Region
1
Bhutan
1
North Korea
1
Italy
1
Armenia
1
Mongolia
1
Laos
1
Timor Leste/ East Timor
1
Qatar
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
212
Clinical Guidelines
73
Public Health
57
Women & Child Health
29
Key Resources
14
Pharmacy & Technologies
4
Capacity Building
1
Toolboxes
COVID-19
222
Mental Health
58
Planetary Health
55
HIV
54
NCDs
48
NTDs
36
TB
31
Disability
21
AMR
18
Caregiver
13
Health Financing Toolbox
13
Pharmacy
12
Global Health Education
9
Ebola & Marburg
8
Natural Hazards
7
Rapid Response
7
Malaria
6
2.0 Rapid Response
4
Conflict
3
Zika
2
Refugee
1
Covid-19 Epidemiological Surveillance Guide: Public Health Emergency of National Importance for Coronavirus Disease 2019 - version 4
Research Article
Karo et al. BMC Infectious Diseases 2014, 14:148 http://www.biomedcentral.com/1471-2334/14/148
Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased risk for Chagas disease transmission is also expected over the next several decades under climate chan
...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di
...
Orientações provisórias23 de Abrilde2020
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog
...
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de
...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim
...
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
Update, 23 de junio de 2022
Orientations provisoires 19 juillet 2021
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM
...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent
...
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de
...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable
...
PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
Available in English, French, Spanish, Chinese, Russian and Arabic
https://apps.who.int/iris/handle/10665/337832
For humanitarian organisations to respond effectively to complex crises, they require access to up-to-date evidence-based guidance. The COVID-19 crisis has highlighted the importance of updating global guidance to context-specific and evolving needs in humanitarian settings. Our study aimed to under
...
Resumen ejecutivo guía de práctica clínica manejo de la infección por Sars-CoV 2